Multidrug resistance in primary tumors and metastases in patients with esophageal squamous cell carcinoma

Pathology and Oncology Research

Volumn 19, Issue 4, 2013, Pages 641-648

  Qiang, Fang ^a   Guangguo, Ren ^a   Yongtao, Han ^a   Dandan, Dong ^b   Hong, Yang ^b  

^a SICHUAN CANCER HOSPITAL   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Esophageal cancer; Lymph node metastasis; Multidrug resistance; Protein expression

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); GLUTATHIONE TRANSFERASE; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIMARY TUMOR; PROTEIN EXPRESSION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM STAGING; STATISTICS, NONPARAMETRIC;

EID: 84885183843     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9623-3     Document Type: Article

References (29)

1. Wolfárd A, Paszt A, Szentpáli K et al (2011) Efficacy and drawbacks of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the thoracic esophagus. Hepatogastroenterology 58:1214-1219
2. Lee PC, Port JL, Paul S et al (2009) Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. Ann Thorac Surg 88:186-192
3. Liu HC, Hung SK, Huang CJ et al (2005) Esophagectomy for locally advanced esophageal cancer, followed by chemoradiotherapy and adjuvant chemotherapy. World J Gastroenterol 11:5367-5372
4. Shiozaki A, Yamagishi H, Itoi H et al (2005) Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer. Oncol Rep 13:667-672
5. Ando N, Iizuka T, Ide H et al (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 21:4592-4596
6. Lee J, Lee KE, Im YH et al (2005) Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma. Ann Thorac Surg 80:1170-1175
7. Ando N, Kato H, Igaki H et al (2012) A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19:68-74
8. Pottgen C, Stuschke M (2012) Radiotherapy versus surgery within multimodality protocols for esophageal cancer-a meta-analysis of the randomized trials. Cancer Treat Rev 38:599-604
9. Yamamoto Y, Yamai H, Seike J et al (2012) Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin. Ann Surg Oncol 19:757-765
10. Donnenberg VS, Donnenberg AD (2005) Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J Clin Pharmacol 45:872-877
11. Takebayashi Y, Akiyama S, Natsugoe S et al (1998) The expression of multidrug resistance protein in human gastrointestinal tract carcinomas. Cancer 82:661-666
12. Tiwari AK, Sodani K, Dai CL et al (2011) Revisiting the ABCs of multidrug resistance in cancer chemotherapy. Curr Pharm Biotechnol 12:570-594
13. Stewart DJ (2010) Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Crit Rev Oncol Hematol 75:173-234
14. Ikeda K, Oka M, Narasaki F et al (1998) Lung resistance-related protein gene expression and drug sensitivity in human gastric and lung cancer cells. Anticancer Res 18:3077-3080
15. Watson RG, Muhale F, Thorne LB et al (2010) Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapy. Eur J Cancer 46:3358-3364
16. Burgess DJ, Doles J, Zender L et al (2008) Topoisomerase levels determine chemotherapy response in vitro and in vivo. Proc Natl Acad Sci U S A 105:9053-9058
17. Gan SY, Zhong XY, Xie SM (2010) Expression and significance of tumor drug resistance related proteins and beta-catenin in esophageal squamous cell carcinoma. Chin J Cancer 29:300-305
18. Becker TE, Ellsworth RE, Deyarmin B et al (2008) The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer. Ann Surg Oncol 15:1056-1063
19. Fleming ID, Cooper JS, Henson DE (1997) Digestive system: Esophagus. In: Flemming ID (ed) AJCC Cancer Staging Manual, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 65-69
20. Sabattini E, Bisgaard K, Ascani S et al (1998) The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 51:506-511
21. Vosse BA, Seelentag W, Bachmann A et al (2007) Background staining of visualization systems in immunohistochemistry: comparison of the Avidin-Biotin Complex system and the EnVision + system. Appl Immunohistochem Mol Morphol 15:103-107
22. Kelty CJ, Kennedy CW, Falk GL (2010) Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma. J Thorac Oncol 5:1467-1471
23. Zhang HL, Chen LQ, Liu RL et al (2010) The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma. Dis Esophagus 23:53-58
24. Zhang J, Chen HQ, Zhang YW et al (2008) Adjuvant chemotherapy in oesophageal cancer: a meta-analysis and experience from the Shanghai Cancer Hospital. J Int Med Res 36:875-882
25. Wang LS, Chow KC, Wu YC et al (2004) Inverse expression of dihydrodiol dehydrogenase and glutathione-S-transferase in patients with esophageal squamous cell carcinoma. Int J Cancer 111:246-251
26. Gillet JP, Gottesman MM (2011) Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer. Curr Pharm Biotechnol 12:686-692
27. Orina JN, Calcagno AM, Wu CP et al (2009) Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database. Mol Cancer Ther 8:2057-2066
28. Shi H, Lu D, Shu Y et al (2008) Expression of multidrug-resistance- related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Cancer Invest 26:344-351
29. Funke S, Timofeeva M, Risch A et al (2010) Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy. Pharmacogenomics 11:33-41